| Name | Safeway Pharmacy #2690 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 4320 Se King Rd, Milwaukie, Oregon 97222 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (503) 659-1840 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
The world is now at a standstill, as many countries have imposed restrictions to stem the spread of the coronavirus disease (COVID-19). Nations are in lockdowns indefinitely, until the situation improves. The vast spread of the novel coronavirus is now inevitable, as the number of confirmed cases topped 1.85 million, many scientists are determining health measures that could help mitigate the global pandemic.
The global fight against HIV/AIDS highlights a "wider argument" about development issues, namely that the "prospects for advance in poor countries depend not just on programs launched within their borders, but also on programs launched in the rich world," a Washington Post editorial says.
› Verified 9 days ago
| NPI Number | 1043231020 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #2690 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4320 Se King Rd, Milwaukie, OR 97222 |
| Phone Number | 503-659-1840 |
News Archive
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
The world is now at a standstill, as many countries have imposed restrictions to stem the spread of the coronavirus disease (COVID-19). Nations are in lockdowns indefinitely, until the situation improves. The vast spread of the novel coronavirus is now inevitable, as the number of confirmed cases topped 1.85 million, many scientists are determining health measures that could help mitigate the global pandemic.
The global fight against HIV/AIDS highlights a "wider argument" about development issues, namely that the "prospects for advance in poor countries depend not just on programs launched within their borders, but also on programs launched in the rich world," a Washington Post editorial says.
› Verified 9 days ago
| NPI Number | 1598725319 |
| Organization Name | RHSO CORP |
| Doing Business As | KING ROAD HI-SCHOOL PHARMCAY #1175 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4200 Se King Rd, Milwaukie, OR 97222 |
| Phone Number | 503-659-1840 |
News Archive
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
The world is now at a standstill, as many countries have imposed restrictions to stem the spread of the coronavirus disease (COVID-19). Nations are in lockdowns indefinitely, until the situation improves. The vast spread of the novel coronavirus is now inevitable, as the number of confirmed cases topped 1.85 million, many scientists are determining health measures that could help mitigate the global pandemic.
The global fight against HIV/AIDS highlights a "wider argument" about development issues, namely that the "prospects for advance in poor countries depend not just on programs launched within their borders, but also on programs launched in the rich world," a Washington Post editorial says.
› Verified 9 days ago
News Archive
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.
The world is now at a standstill, as many countries have imposed restrictions to stem the spread of the coronavirus disease (COVID-19). Nations are in lockdowns indefinitely, until the situation improves. The vast spread of the novel coronavirus is now inevitable, as the number of confirmed cases topped 1.85 million, many scientists are determining health measures that could help mitigate the global pandemic.
The global fight against HIV/AIDS highlights a "wider argument" about development issues, namely that the "prospects for advance in poor countries depend not just on programs launched within their borders, but also on programs launched in the rich world," a Washington Post editorial says.
› Verified 9 days ago
Bellevue Healthcare Ii Inc Portland Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3601 Se Concord Rd, Milwaukie, Oregon 97267 Phone: (503) 659-1270 | |
Eyehealth Northwest Type: Eyewear Supplier (Equipment, not the service) Location: 11086 Se Oak St, Milwaukie, Oregon 97222 Phone: (503) 344-5170 | |
Fred Meyer Pharmacy 240 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14700 Se Mcloughlin Blvd, Milwaukie, Oregon 97267 Phone: (503) 652-4133 | |
Keen Mobility Company Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9510 Se Main St, Milwaukie, Oregon 97222 Phone: (866) 737-5866 | |
Northwest Primary Care Group Pc Type: Medicare Supplier Location: 10024 Se 32nd Ave, Milwaukie, Oregon 97222 Phone: (503) 659-4988 |